Taysha Gene Therapies shares owned by Barclays
Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Taysha Gene Therapies
Tip: Access up to 7 years of quarterly data
All positions including Taysha Gene Therapies held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Taysha Gene Therapies by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $17M | 5.1M | 3.27 |
| 2025-06-30 | $1.0M | 451k | 2.31 |
| 2025-03-31 | $985k | 709k | 1.39 |
| 2024-12-31 | $587k | 335k | 1.75 |
| 2024-09-30 | $513k | 247k | 2.07 |
| 2024-06-30 | $118k | 54k | 2.18 |
| 2022-12-31 | $97k | 44k | 2.20 |
| 2022-09-30 | $97k | 48k | 2.03 |
| 2022-06-30 | $184k | 48k | 3.84 |
| 2022-03-31 | $273k | 44k | 6.15 |